China Regenerative Medicine International Limited (HKG:8158)

HKG:8158 Revenue

In the year 2025, China Regenerative Medicine International had annual revenue of 72.06M HKD, down -20.48%. China Regenerative Medicine International had revenue of 44.66M in the half year ending December 31, 2025.

• Revenue: 72.06M
• Revenue Growth: -20.48%
• P/S Ratio: 1.35
• Revenue / Employee: 2.40M
• Employees: 30
• Market Cap: 97.36M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	72.06M	-18.56M	-20.48%
Dec 31, 2024	90.62M	21.13M	30.41%
Dec 31, 2023	69.49M	27.95M	67.29%
Dec 31, 2022	41.54M	-241.36M	-85.32%
Dec 31, 2021	282.90M	100.76M	55.32%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 24, 2026

Data Sources Report a data error